Chlamydophila pneumoniae: Difference between revisions
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*An obligate intracellular bacteria | *An [[Non-culture growing bacteria|obligate intracellular bacteria]] | ||
*Common cause of community-acquired [[pneumonia]], particularly an [[atypical pneumonia]] | *Common cause of community-acquired [[pneumonia]], particularly an [[atypical pneumonia]] | ||
*Most recent studies have shown that <1% of cases of community acquired penumonia are caused by chlamydia pneumoniae | *Most recent studies have shown that <1% of cases of community acquired penumonia are caused by chlamydia pneumoniae | ||
Revision as of 10:20, 8 September 2016
Background
- An obligate intracellular bacteria
- Common cause of community-acquired pneumonia, particularly an atypical pneumonia
- Most recent studies have shown that <1% of cases of community acquired penumonia are caused by chlamydia pneumoniae
Differential Diagnosis
Causes of Pneumonia
Bacteria
Viral
- Common
- Influenza
- Respiratory syncytial virus
- Parainfluenza
- Rarer
- Adenovirus
- Metapneumovirus
- Severe acute respiratory syndrome (SARS)
- Middle east respiratory syndrome coronavirus (MERS)
- 2019-nCoV (COVID-19)
- Cause other diseases, but sometimes cause pneumonia
Fungal
- Histoplasmosis
- Coccidioidomycosis
- Blastomycosis
- Pneumocystis jirovecii pneumonia (PCP)
- Sporotrichosis
- Cryptococcosis
- Aspergillosis
- Candidiasis
Parasitic
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014